Clinical Trials Browser

ER+ HER2- Advanced Breast Cancer × Clear all

NCT06188520 2026-05-11

CYCAD-1

Phase 1/2 Recruiting

BreastGynecologic

ER+ HER2- Advanced Breast Cancer

NCT03596658 2022-09-01

SHR9549 in ER Positive HER2 Negative Advanced Breast Cancer

Phase 1 Terminated

ER+ HER2- Advanced Breast Cancer

NCT02248090 2019-06-24

AZD9496 First Time in Patients Ascending Dose Study

Phase 1 Completed

ER+ HER2- Advanced Breast Cancer